Development of sphingosine kinase (SPHK) inhibitors and the role of sphingolipids in adult stem cell proliferation and differentiation 6

Chapter 6 References

158
CHAPTER 6 REFERENCES

Alemany, R., D. Meyer Zu Heringdorf, et al. (1999). "Formyl peptide receptor signaling
in HL-60 cells through sphingosine kinase." J Biol Chem 274(7): 3994-9.

Ammit, A. J., A. T. Hastie, et al. (2001). "Sphingosine 1-phosphate modulates human
airway smooth muscle cell functions that promote inflammation and airway remodeling
in asthma." Faseb J 15(7): 1212-4.

Ancellin, N., C. Colmont, et al. (2002). "Extracellular export of sphingosine kinase-1
enzyme. Sphingosine 1-phosphate generation and the induction of angiogenic vascular
maturation." J Biol Chem 277(8): 6667-75.

Argraves, K. M., B. A. Wilkerson, et al. (2004). "Sphingosine-1-phosphate signaling
promotes critical migratory events in vasculogenesis." J Biol Chem 279(48): 50580-90.

Ashjian, P. H., A. S. Elbarbary, et al. (2003). "In vitro differentiation of human processed
lipoaspirate cells into early neural progenitors." Plast Reconstr Surg 111(6): 1922-31.

Auge, N., M. Nikolova-Karakashian, et al. (1999). "Role of sphingosine 1-phosphate in
the mitogenesis induced by oxidized low density lipoprotein in smooth muscle cells via
activation of sphingomyelinase, ceramidase, and sphingosine kinase." J Biol Chem
274(31): 21533-8.

Auge, N., A. Negre-Salvayre, et al. (2000) “Sphingomyelin metabolites in vascular cell
signaling and atherogenesis.” Prog. Lipid Res. 39:207–229.

Bacou, F., R. B. el Andalousi, et al. (2004). "Transplantation of adipose tissue-derived

stromal cells increases mass and functional capacity of damaged skeletal muscle." Cell
Transplant 13(2): 103-11.

Bai Aiping, G. Patrick Meier, et al. (2004). “Prodrug modification increases D609
chemical stability and cytotoxicity agaist U937 leukemia cells”. JPET Fast Forward.
309:1051-9.

Baumruker, T. and E. E. Prieschl (2002). "Sphingolipids and the regulation of the
immune response." Semin Immunol 14(1): 57-63.

Behfar, A. and A. Terzic (2007). "Optimizing adult mesenchymal stem cells for heart
repair." J Mol Cell Cardiol 42(2): 283-4.

Benoit, D. S. and K. S. Anseth (2005). "Heparin functionalized PEG gels that modulate
protein adsorption for hMSC adhesion and differentiation." Acta Biomater 1(4): 461-70.

Chapter 6 References

159
Benvenuti, S., R. Saccardi, et al. (2006). "Neuronal differentiation of human
mesenchymal stem cells: changes in the expression of the Alzheimer's disease-related
gene seladin-1." Exp Cell Res 312(13): 2592-604.

Bernatchez, P. N., F. Tremblay, et al. (2003). "Sphingosine 1-phosphate effect on
endothelial cell PAF synthesis: role in cellular migration." J Cell Biochem 90(4): 719-31.

Biddulph, D. M., M. M. Dozier, et al. (2000). "Inhibition of prostaglandin synthesis
reduces cyclic AMP levels and inhibits chondrogenesis in cultured chick limb
mesenchyme." Methods Cell Sci 22(1): 9-16.

Bielby, R., E. Jones, et al. (2007). "The role of mesenchymal stem cells in maintenance
and repair of bone." Injury 38 Suppl 1: S26-32.

Bielawska, A., Szulc, Z., and Hannun, Y. (2000) "A. Synthesis of key precursors of
radiolabeled sphingolipids." Methods Enzymol., 311: 518-535.
Billich A, Bornancin F, et al. (2003) "Phosphorylation of the immunomodulatory drug
FTY720 by sphingosine kinases". J Biol Chem 278 (48): 47408–15.

Blakolmer, K., K. Jaskiewicz, et al. (1995). "Hematopoietic stem cell markers are
expressed by ductal plate and bile duct cells in developing human liver." Hepatology
21(6): 1510-6.

Brinkmann, V. Michael D. Davis, et al. (2002) “The immune modulator, FTY720, targets
sphingosine 1-phosphate receptors.” J. Biol. Chem. 277, 21453-21457

Bruder, S. P., N. Jaiswal, et al. (1997). "Growth kinetics, self-renewal, and the osteogenic
potential of purified human mesenchymal stem cells during extensive subcultivation and
following cryopreservation." J Cell Biochem 64(2): 278-94.

Bussolati, B., S. Bruno, et al. (2005). "Isolation of renal progenitor cells from adult
human kidney." Am J Pathol 166(2): 545-55.

Cao, Tong, Boon Chin Henga, et al. (2005) “Osteogenic differentiation within intact
human embryoid bodies result in a marked increase in osteocalcin secretion after 12 days
of in vitro culture, and formation of morphologically distinct nodule-like structures”
Tissue and Cell 37:325-34

Chastain, S. R., A. K. Kundu, et al. (2006). "Adhesion of mesenchymal stem cells to
polymer scaffolds occurs via distinct ECM ligands and controls their osteogenic
differentiation." J Biomed Mater Res A 78(1): 73-85.

Chen, X. L., J. Y. Grey, et al. (2004). "Sphingosine kinase-1 mediates TNF-alpha-
induced MCP-1 gene expression in endothelial cells: upregulation by oscillatory flow."
Am J Physiol Heart Circ Physiol 287(4): H1452-8.
Chapter 6 References

160
Chen, Y., F. Y. Teng, et al. (2006). "Coaxing bone marrow stromal mesenchymal stem
cells towards neuronal differentiation: progress and uncertainties." Cell Mol Life Sci
63(14): 1649-57.

Cheng, Su-Li, Jian-Su Shao, et al. (2003) “Msx2 Promotes Osteogenesis and Suppresses
Adipogenic Differentiation of Multipotent Mesenchymal Progenitors” J. Biol. Chem.,
278(46):45969-77

Chiba, K., Y. Yanagawa, et al. (1998). "FTY720, a novel immunosuppressant, induces
sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in
rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by
acceleration of lymphocyte homing." J Immunol 160(10): 5037-44.

Chiou, M., Y. Xu, et al. (2006). "Mitogenic and chondrogenic effects of fibroblast
growth factor-2 in adipose-derived mesenchymal cells." Biochem Biophys Res Commun
343(2): 644-52.

Choi, O. H., J. H. Kim, et al. (1996). "Calcium mobilization via sphingosine kinase in
signalling by the Fc epsilon RI antigen receptor." Nature 380(6575): 634-6.
Chun, Jerold, Edward J. Goetzl, et al. (2002) “Lysophospholipid Receptor
Nomenclature.” International Union of Pharmacology. 54(2): 265-269
Cipriani, P., S. Guiducci, et al. (2007). "Impairment of endothelial cell differentiation
from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of

systemic sclerosis." Arthritis Rheum 56(6): 1994-2004.

Clark, B. R. and A. Keating (1995). "Biology of bone marrow stroma." Ann N Y Acad
Sci 770: 70-8.

Conget, P. A. and J. J. Minguell (1999). "Phenotypical and functional properties of
human bone marrow mesenchymal progenitor cells." J Cell Physiol 181(1): 67-73.

Corcione, A., F. Benvenuto, et al. (2006). "Human mesenchymal stem cells modulate B-
cell functions." Blood 107(1): 367-72.

Cousin, B., M. Andre, et al. (2003). "Reconstitution of lethally irradiated mice by cells
isolated from adipose tissue." Biochem Biophys Res Commun 301(4): 1016-22.

Cowan, C. M., Y. Y. Shi, et al. (2004). "Adipose-derived adult stromal cells heal critical-
size mouse calvarial defects." Nat Biotechnol 22(5): 560-7.

Crews, C. M., A. Alessandrini, et al. (1992). "The primary structure of MEK, a protein
kinase that phosphorylates the ERK gene product." Science 258(5081): 478-80.

Chapter 6 References

161
Cummings, R. J., N. L. Parinandi, et al. (2002). "Phospholipase D activation by
sphingosine 1-phosphate regulates interleukin-8 secretion in human bronchial epithelial
cells." J Biol Chem 277(33): 30227-35.

Cuvillier, O., G. Pirianov, et al. (1996). "Suppression of ceramide-mediated programmed
cell death by sphingosine-1-phosphate." Nature 381(6585): 800-3.

Cuvillier, O., D. S. Rosenthal, et al. (1998). "Sphingosine 1-phosphate inhibits activation
of caspases that cleave poly(ADP-ribose) polymerase and lamins during Fas- and
ceramide-mediated apoptosis in Jurkat T lymphocytes." J Biol Chem 273(5): 2910-6.

Dekel, B., S. Metsuyanim, et al. (2006). "Multiple imprinted and stemness genes provide
a link between normal and tumor progenitor cells of the developing human kidney."
Cancer Res 66(12): 6040-9.

Desai, NN, H Zhang et al. (1992) “Sphingosine-1-phosphate, a metabolite of sphingosine,
increases phosphatidic acid levels by phospholipase D activation.” J. Biol. Chem. 267:
23122-23128.

Deutschman, D. H., J. S. Carstens, et al. (2003). "Predicting obstructive coronary artery
disease with serum sphingosine-1-phosphate." Am Heart J 146(1): 62-8.

Dimarakis, I. and N. Levicar (2006). "Cell culture medium composition and translational
adult bone marrow-derived stem cell research." Stem Cells 24(5): 1407-8.

Djouad, F., D. Mrugala, et al. (2006). "Engineered mesenchymal stem cells for cartilage
repair." Regen Med 1(4): 529-37.
Donati, Chiara, Francesca Cencetti, et al. (2007) “Sphingosine 1-phosphate mediates
proliferation and survival of mesoangioblasts.” Stem cells. 25(7):1713-1719
Dragoo, J. L., J. Y. Choi, et al. (2003). "Bone induction by BMP-2 transduced stem cells
derived from human fat." J Orthop Res 21(4): 622-9.

Drouet, M., F. Mourcin, et al. (2005). "Mesenchymal stem cells rescue CD34+ cells from
radiation-induced apoptosis and sustain hematopoietic reconstitution after coculture and
cografting in lethally irradiated baboons: is autologous stem cell therapy in nuclear
accident settings hype or reality?" Bone Marrow Transplant 35(12): 1201-9.

Duan, H. F., C. T. Wu, et al. (2004). "Sphingosine kinase activation regulates hepatocyte
growth factor induced migration of endothelial cells." Exp Cell Res 298(2): 593-601.

Edsall, L. C., G. G. Pirianov, et al. (1997). "Involvement of sphingosine 1-phosphate in
nerve growth factor-mediated neuronal survival and differentiation." J Neurosci 17(18):
6952-60.

Chapter 6 References

162
Edsall, Lisa C, James R. Van Brocklyn, et al. (1998) “N,N-Dimethylsphingosine Is a
Potent Competitive Inhibitor of Sphingosine Kinase but Not of Protein Kinase C:
Modulation of Cellular Levels of Sphingosine 1-Phosphate and Ceramide.” Biochemistry,
37 (37), 12892 -12898

English, D., Z. Welch, et al. (2000). "Sphingosine 1-phosphate released from platelets
during clotting accounts for the potent endothelial cell chemotactic activity of blood
serum and provides a novel link between hemostasis and angiogenesis." Faseb J 14(14):
2255-65.

Enlund, F., L. Samuelsson, et al. (1999). "Analysis of three suggested psoriasis
susceptibility loci in a large Swedish set of families: confirmation of linkage to
chromosome 6p (HLA region), and to 17q, but not to 4q." Hum Hered 49(1): 2-8.

Erickson, G. R., J. M. Gimble, et al. (2002). "Chondrogenic potential of adipose tissue-
derived stromal cells in vitro and in vivo." Biochem Biophys Res Commun 290(2): 763-9.

Farquharson, C., J. L. Berry, et al. (1998). "Ascorbic acid-induced chondrocyte terminal
differentiation: the role of the extracellular matrix and 1,25-dihydroxyvitamin D." Eur J
Cell Biol 76(2): 110-8.

Frankish, H. (2001). "Researchers turn human stem cells into heart tissue." Lancet
358(9280): 475.

French, K. J., R. S. Schrecengost, et al. (2003). "Discovery and evaluation of inhibitors of
human sphingosine kinase." Cancer Res 63(18): 5962-9.

Friedenstein, A. J., K. V. Petrakova, et al. (1968). "Heterotopic of bone marrow.Analysis
of precursor cells for osteogenic and hematopoietic tissues." Transplantation 6(2): 230-47.

Fukuda, K. and J. Fujita (2005). "Mesenchymal, but not hematopoietic, stem cells can be
mobilized and differentiate into cardiomyocytes after myocardial infarction in mice."
Kidney Int 68(5): 1940-3.

Garner, P., Park, J. M., and Malecki, E. (1988) "A stereodivergent synthesis of D-
erythro-sphingosine and D-threo-sphingosine from L-serine." J. Org. Chem., 53: 4395-
4398

Gaustad, K. G., A. C. Boquest, et al. (2004). "Differentiation of human adipose tissue
stem cells using extracts of rat cardiomyocytes." Biochem Biophys Res Commun 314(2):
420-7.

Gearhart, J. (1998). "New potential for human embryonic stem cells." Science 282(5391):
1061-2.

Chapter 6 References

163
Geoffroy, K., N. Wiernsperger, et al. (2004). "Bimodal effect of advanced glycation end
products on mesangial cell proliferation is mediated by neutral ceramidase regulation and

endogenous sphingolipids." J Biol Chem 279(33): 34343-52.

Gerstenfeld, L. C., T. J. Cho, et al. (2001). "Impaired intramembranous bone formation
during bone repair in the absence of tumor necrosis factor-alpha signaling." Cells Tissues
Organs 169(3): 285-94.

Ghen, M. J., R. Roshan, et al. (2006). "Potential clinical applications using stem cells
derived from human umbilical cord blood." Reprod Biomed Online 13(4): 562-72.

Ghosh, TK, Bian J, et al. (1990). “Intracellular calcium release mediated by sphingosine
derivatives generated in cells.” Science, 248: 1653-1656

Gimble, J. M., S. Zvonic, et al. (2006). "Playing with bone and fat." J Cell Biochem
98(2): 251-66.

Giordano, A., U. Galderisi, et al. (2007). "From the laboratory bench to the patient's
bedside: an update on clinical trials with mesenchymal stem cells." J Cell Physiol 211(1):
27-35.

Gordon, E. M., M. Skotzko, et al. (1997). "Capture and expansion of bone marrow-
derived mesenchymal progenitor cells with a transforming growth factor-beta1-von
Willebrand's factor fusion protein for retrovirus-mediated delivery of coagulation factor
IX." Hum Gene Ther 8(11): 1385-94.

Grigoriadis, A. E., J. N. Heersche, et al. (1988). "Differentiation of muscle, fat, cartilage,
and bone from progenitor cells present in a bone-derived clonal cell population: effect of
dexamethasone." J Cell Biol 106(6): 2139-51.

Hait, Nitai C., Andrea Bellamy, et al. (2007) “Sphingosine kinase type 2 activation by
ERK-mediated phosphorylation.” J Bio. Chem. 282(16):12058-65

Hait, Nitai C, Sukumar Sarkar, et al. (2005) “ Role of Sphingosine Kinase 2 in cell
migration toward epidermal growth factor.” J. Biol. Chem., 280(33):29462-9

Hanafusa, N., Y. Yatomi, et al. (2002). "Sphingosine 1-phosphate stimulates rat
mesangial cell proliferation from outside the cells." Nephrol Dial Transplant 17(4): 580-6.
Hannun, Y. A. (1994). "The sphingomyelin cycle and the second messenger function of
ceramide." J Biol Chem 269(5): 3125-8.

Harada, J., M. Foley, et al. (2004). "Sphingosine-1-phosphate induces proliferation and
morphological changes of neural progenitor cells." J Neurochem 88(4): 1026-39.

Chapter 6 References

164
Harmand, M. F., M. Thomasset, et al. (1984). "In vitro stimulation of articular
chondrocyte differentiated function by 1,25-dihydroxycholecalciferol or 24R,25-
dihydroxycholecalciferol." J Cell Physiol 119(3): 359-65.

Heller, R. A. and M. Kronke (1994). "Tumor necrosis factor receptor-mediated signaling
pathways." J Cell Biol 126(1): 5-9.

Heng, BC, T Cao, et al. (2004) “Strategies for directing the differentiation of stem cells
into the osteogenic lineage in vitro.” J Bone Miner Res 19:1379–1394.

Hentze, H, Graichen R, et al. (2007) “Cell therapy and the safety of embryonic stem cell-
derived grafts.” Trends Biotechno 25:24-32

Herold, P. (1988) "Synthesis of D-erythro- and D-threo-sphingosine derivatives from L-
serine." Helv. Chim. Acta, 71: 354-362.

Herbertson, A. and J. E. Aubin (1995). "Dexamethasone alters the subpopulation make-
up of rat bone marrow stromal cell cultures." J Bone Miner Res 10(2): 285-94.

Hicok, K. C., T. V. Du Laney, et al. (2004). "Human adipose-derived adult stem cells
produce osteoid in vivo." Tissue Eng 10(3-4): 371-80.

Hla, T. (2004). "Physiological and pathological actions of sphingosine 1-phosphate."
Semin Cell Dev Biol 15(5): 513-20.

Hla, T. and T. Maciag (1990). "An abundant transcript induced in differentiating human
endothelial cells encodes a polypeptide with structural similarities to G-protein-coupled
receptors." J Biol Chem 265(16): 9308-13.

Hong, G., L. M. Baudhuin, et al. (1999). "Sphingosine-1-phosphate modulates growth
and adhesion of ovarian cancer cells." FEBS Lett 460(3): 513-8.

Huang, J. I., S. R. Beanes, et al. (2002). "Rat extramedullary adipose tissue as a source of
osteochondrogenic progenitor cells." Plast Reconstr Surg 109(3): 1033-41; discussion
1042-3.

Huang, S. and L. W. Terstappen (1992). "Formation of haematopoietic microenvironment
and haematopoietic stem cells from single human bone marrow stem cells." Nature
360(6406): 745-9.

Hwang, N. S., S. Varghese, et al. (2007). "Morphogenetic signals from chondrocytes
promote chondrogenic and osteogenic differentiation of mesenchymal stem cells." J Cell
Physiol 212(2): 281-4.

Ibrahim, F. B., S. J. Pang, and A. J. Melendez. (2004). "Anaphylatoxin signaling in

human neutrophils. A key role for sphingosine kinase." J Biol Chem 279(43): 44802-11.
Chapter 6 References

165
Igarashi, Y. and S. Hakomori (1989). "Enzymatic synthesis of N,N-dimethyl-sphingosine:
demonstration of the sphingosine: N-methyltransferase in mouse brain." Biochem
Biophys Res Commun 164(3): 1411-6.

Igarashi, Y., S. Hakomori, et al. (1989). "Effect of chemically well-defined sphingosine
and its N-methyl derivatives on protein kinase C and src kinase activities." Biochemistry
28(17): 6796-800.

Ikeda, H., Y. Yatomi, et al. (2000). "Biological activities of novel lipid mediator
sphingosine 1-phosphate in rat hepatic stellate cells." Am J Physiol Gastrointest Liver
Physiol 279(2): G304-10.

Im, G. I., N. H. Jung, et al. (2006). "Chondrogenic differentiation of mesenchymal stem
cells isolated from patients in late adulthood: the optimal conditions of growth factors."
Tissue Eng 12(3): 527-36.

Im, Dong-Soon, Christopher E. Heise, et al. (2000) “Characterization of a novel
sphingosine 1-phosphate Receptor, Edg-8.” Biol Chem, 275(19):14281-14286

Isakova, I. A., K. Baker, et al. (2006). "Preclinical evaluation of adult stem cell
engraftment and toxicity in the CNS of rhesus macaques." Mol Ther 13(6): 1173-84.

Ishii, I., B. Friedman, et al. (2001). "Selective loss of sphingosine 1-phosphate signaling
with no obvious phenotypic abnormality in mice lacking its G protein-coupled receptor,
LP(B3)/EDG-3." J Biol Chem 276(36): 33697-704.

Ishii, Isao, Xiaoqin Ye, et al. (2002) “Marked perinatal lethality and cellular signaling
deficits in mice null for the two sphingosine 1-phosphate (S1P) receptors,
S1P
2
/LP
B2
/EDG-5 and S1P
3
/LP
B3
/EDG-3”. J. Biol. Chem., 277(28):25152-9

Jailard, C., S. Harrison, et al. (2005) “Edg8/S1P5: An oligodendroglial receptor with dual
function on process retraction and cell survival.” J NeuroSci. 25(6):1459-69

Jaiswal, Rama K., Neelam Jaiswal, et al. (2000) “Adult human mesenchymal stem cell
differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated
protein kinase.” J. Biol. Chem., 275(13):9645-52.

Jian, H., X. Shen, et al. (2006). "Smad3-dependent nuclear translocation of beta-catenin
is required for TGF-beta1-induced proliferation of bone marrow-derived adult human
mesenchymal stem cells." Genes Dev 20(6): 666-74.

Jin, Zhu-Qiu, Joel S. Karliner (2006) “Low dose N,N-dimethylsphingosine is
cardioprotective and activates cytosolic sphingosine kinase by a PKCε dependent
mechanism.” Cardiovascular Res. 71:725-34

Chapter 6 References

166

Joannides, A., P. Gaughwin, et al. (2004). "Efficient generation of neural precursors from
adult human skin: astrocytes promote neurogenesis from skin-derived stem cells." Lancet
364(9429): 172-8.

Johansson, C. B., M. Svensson, et al. (1999). "Neural stem cells in the adult human
brain." Exp Cell Res 253(2): 733-6.

Johnstone, B., T. M. Hering, et al. (1998). "In vitro chondrogenesis of bone marrow-
derived mesenchymal progenitor cells." Exp Cell Res 238(1): 265-72.

Jolly, P. S., M. Bektas, et al. (2004). "Transactivation of sphingosine-1-phosphate
receptors by FcepsilonRI triggering is required for normal mast cell degranulation and
chemotaxis." J Exp Med 199(7): 959-70.

Kakudo, N., A. Shimotsuma, et al. (2007). "Fibroblast growth factor-2 stimulates
adipogenic differentiation of human adipose-derived stem cells." Biochem Biophys Res
Commun 359(2): 239-44.

Kaiser, E., Tam, J. P., et al. (1988) "Chlorotrimethylsilane-phenol as a mild deprotection
reagent for the tert-butyl based protecting groups in peptide synthesis.” Tetrahedron Lett.,
29: 303-306.

Kang, Y. J., E. S. Jeon, et al. (2005). "Role of c-Jun N-terminal kinase in the PDGF-
induced proliferation and migration of human adipose tissue-derived mesenchymal stem
cells." J Cell Biochem 95(6): 1135-45.

Katsuma, S., Y. Hada, et al. (2003). "Transcriptional profiling of gene expression
patterns during sphingosine 1-phosphate-induced mesangial cell proliferation." Biochem
Biophys Res Commun 300(2): 577-84.

Katsuma, S., Y. Hada, et al. (2002). "Signalling mechanisms in sphingosine 1-phosphate-
promoted mesangial cell proliferation." Genes Cells 7(12): 1217-30.

Kee, T. H., P. Vit, et al. (2005). "Sphingosine kinase signalling in immune cells." Clin
Exp Pharmacol Physiol 32(3): 153-61.

Khovidhunkit, Weerapan, MinSun Kim, et al. (2004) “Effects of Infection and
Inflammation on Lipid and Lipoprotein Metabolism: Mechanisms and Consequences to
the Host” J Lipid Res. 45(7):1169-96

Kilian, O., I. Flesch, et al. (2004). "Effects of platelet growth factors on human
mesenchymal stem cells and human endothelial cells in vitro." Eur J Med Res 9(7): 337-
44.

Chapter 6 References

167
Kim, S. S., J. M. Choi, et al. (2005). "cAMP induces neuronal differentiation of
mesenchymal stem cells via activation of extracellular signal-regulated kinase/MAPK."
Neuroreport 16(12): 1357-61.

Kim, Jin-Wook, Yong-Woo Kim, et al. (2005) “Synthesis and evaluation of sphingoid
analogs as inhibitors of sphingosine kinases.” Bioorganic & Medicinal Chemistry 13:
3475-3485

Kim, Ji Young, Kristin S. Tillison, et al. (2007) “Differentiation-dependent expression of
adhfel in adipogenesis.” Arch Biochem Biophys. 464(1):100-111.

Kim, Hyo-Lim, Santosh J. Sacket, et al. (2008) “Charaterization of N,N-dimethyl-D-
erythro-sphingosine-induced apoptosis and signaling in U937 cells: Independece of

sphingosine kinase inhibition.” Prostaglandins & other lipid Mediators 86: 18-25

Kim, Hyo-Lim, Santosh J. Sacket, et al. (2008) “Characterization of N, N-dimethyl-d-
erythro-sphingosine-induced apoptosis and signaling in U937 cells: independence of
sphingosine kinase inhibition.” Prostaglandins & Other Lipid Mediators. 86(1-4):18-25

Kimura, T., T. Watanabe, et al. (2000). "Sphingosine 1-phosphate stimulates proliferation
and migration of human endothelial cells possibly through the lipid receptors, Edg-1 and
Edg-3." Biochem J 348 Pt 1: 71-6.

Kimura, T., K. Sato, et al. (2001) “Sphingosine 1-phosphate may be a major component
of plasma lipoproteins responsible for the cytoprotective actions in human umbilical vein
endothelial cells.” J. Biol. Chem. 276:31780–31785.

King, C. C., Zenke, F. T., et al. (2000) “Sphingosine is a novel activator of 3-
phosphoinositide-dependent kinase 1.” J. Biol. Chem., 275: 18108-18113

Kluk, M. J. and T. Hla (2001). "Role of the sphingosine 1-phosphate receptor EDG-1 in
vascular smooth muscle cell proliferation and migration." Circ Res 89(6): 496-502.

Kluk, Michael J. and Timothy Hla. (2002) “Signaling of sphingosine-1-phosphate via the
S1P/EDG-family of G-protein-coupled receptors.” Biochimica et Biophysica Acta
1582:72-80

Koda, Masahiro, Takashi Murate et al. (2005) “Sphingosine kinase 1 is involved in
dibutyryl cyclic AMP-induced granulocytic differentiation through the upregulation of
extracellular signal-regulated kinase, but not p38 MAP kinase, in HL60 cells”
Biochimica et Biophysica Acta 1733:101– 10

Kogler, G., S. Sensken, et al. (2006). "Comparative generation and characterization of

pluripotent unrestricted somatic stem cells with mesenchymal stem cells from human
cord blood." Exp Hematol 34(11): 1589-95.

Chapter 6 References

168
Kohama, T., A. Olivera, et al. (1998). "Molecular cloning and functional characterization
of murine sphingosine kinase." J Biol Chem 273(37): 23722-8.

Kohsaki, M., B. Yanes, et al. (1981). "Non-frozen preservation of committed
hematopoietic stem cells from normal human bone marrow." Stem Cells 1(2): 111-23.

Kolesnick, R. and D. W. Golde (1994). "The sphingomyelin pathway in tumor necrosis
factor and interleukin-1 signaling." Cell 77(3): 325-8.

Kono, K., Tanaka, M., et al. (2000a) “B-535a, b and c, new sphingosine kinase inhibitors,
produced by a marine bacterium; taxonomy, fermentation, isolation, physico-chemical
properties and structure determination.” J. Antibiot. (Tokyo), 53: 753-758

Kono, K., Tanaka, M., et al. (2000b) “Characterization of B-5354c, a new sphingosine
kinase inhibitor, produced by a marine bacterium.” J. Antibiot. (Tokyo), 53: 759-764

Kono, K., Tanaka, M., et al. (2001) “S-15183a and b, new sphingosine kinase inhibitors,
produced by a fungus.” J. Antibiot. (Tokyo), 54: 415-420

Krampera, M., G. Pizzolo, et al. (2006). "Mesenchymal stem cells for bone, cartilage,
tendon and skeletal muscle repair." Bone 39(4): 678-83.

Kratchmarova, I., B. Blagoev, et al. (2005). "Mechanism of divergent growth factor
effects in mesenchymal stem cell differentiation." Science 308(5727): 1472-7.

Kronenwett, R., S. Martin, et al. (2000). "The role of cytokines and adhesion molecules
for mobilization of peripheral blood stem cells." Stem Cells 18(5): 320-30.

Kukekov, V. G., E. D. Laywell, et al. (1999). "Multipotent stem/progenitor cells with
similar properties arise from two neurogenic regions of adult human brain." Exp Neurol
156(2): 333-44.

Kumar, S., G. Mahendra, et al. (2004). "Osteogenic differentiation of recombinant adeno-
associated virus 2-transduced murine mesenchymal stem cells and development of an
immunocompetent mouse model for ex vivo osteoporosis gene therapy." Hum Gene Ther
15(12): 1197-206.

Kundu, A. K. and A. J. Putnam (2006). "Vitronectin and collagen I differentially regulate
osteogenesis in mesenchymal stem cells." Biochem Biophys Res Commun 347(1): 347-
57.

Kuno, Yuko, Teruaki Nishiuma, et al. (2007) “Sphingosine kinase 1 regulates
differentiation of human and mouse lung fibroblasts mediated by TGF-beta1.” Am J
Respir Cell Mol Biol Vol 37: 395-404, 2007

Chapter 6 References

169
Kuokkanen, S., M. Gschwend, et al. (1997). "Genomewide scan of multiple sclerosis in
Finnish multiplex families." Am J Hum Genet 61(6): 1379-87.

Kupperman, E., S. An, et al. (2000). "A sphingosine-1-phosphate receptor regulates cell
migration during vertebrate heart development." Nature 406(6792): 192-5.

Latif, N., P. Sarathchandra, et al. (2007). "Characterization of structural and signaling
molecules by human valve interstitial cells and comparison to human mesenchymal stem
cells." J Heart Valve Dis 16(1): 56-66.

Lee, I. C., J. H. Wang, et al. (2007). "The differentiation of mesenchymal stem cells by
mechanical stress or/and co-culture system." Biochem Biophys Res Commun 352(1):
147-52.

Lee, M. J., S. Thangada, et al. (1999). "Vascular endothelial cell adherens junction
assembly and morphogenesis induced by sphingosine-1-phosphate." Cell 99(3): 301-12.

Lee, M. J., S. Thangada, et al. (2001). "Akt-mediated phosphorylation of the G protein-
coupled receptor EDG-1 is required for endothelial cell chemotaxis." Mol Cell 8(3): 693-
704.

Lee, R. H., B. Kim, et al. (2004). "Characterization and expression analysis of
mesenchymal stem cells from human bone marrow and adipose tissue." Cell Physiol
Biochem 14(4-6): 311-24.

Lee, Eun-Hee, Yun-Kyung Lee, et al. (2006) “Dimethylsphingosine regulates
intracellular pH and Ca
2+
in human monocytes.” J Pharma. Sci. 100 (4): 289-296

Leong Tai Wei David. (2006a) "Characterization of human adipose derived adult
multipotent precursor cells" (NUS PhD thesis)

Leong, D. T., A. Gupta, et al. (2007). "Absolute quantification of gene expression in
biomaterials research using real-time PCR." Biomaterials 28(2): 203-10.

Leong, Natalie L., Jie Jiang et al. (2006b). “Polymer-Ceramic composite scaffold induces
osteogenic differentiation of human mesenchymal stem cells.” EMBS Annual
International Conference New York City, USA, Aug 30-Sept 3, 2006

Levenstein, M. E., T. E. Ludwig, et al. (2006). "Basic fibroblast growth factor support of
human embryonic stem cell self-renewal." Stem Cells 24(3): 568-74.

Levesque, J. P., Y. Takamatsu, et al. (2001). "Vascular cell adhesion molecule-1 (CD106)
is cleaved by neutrophil proteases in the bone marrow following hematopoietic
progenitor cell mobilization by granulocyte colony-stimulating factor." Blood 98(5):
1289-97.

Chapter 6 References

170
Li, X., X. Yu, et al. (2007). "Bone marrow mesenchymal stem cells differentiate into
functional cardiac phenotypes by cardiac microenvironment." J Mol Cell Cardiol 42(2):
295-303.

Li, Z. Y., L. Chen, et al. (2007). "Odontogenic potential of bone marrow mesenchymal
stem cells." J Oral Maxillofac Surg 65(3): 494-500.

Limaye, V., X. Li, et al. (2005). "Sphingosine kinase-1 enhances endothelial cell survival
through a PECAM-1-dependent activation of PI-3K/Akt and regulation of Bcl-2 family
members." Blood 105(8): 3169-77.

Liu, H., D. Chakravarty, et al. (2002). "Sphingosine kinases: a novel family of lipid
kinases." Prog Nucleic Acid Res Mol Biol 71: 493-511.

Liu, H., M. Sugiura, et al. (2000). "Molecular cloning and functional characterization of a

novel mammalian sphingosine kinase type 2 isoform." J Biol Chem 275(26): 19513-20.

Liu, Y., R. Wada, et al. (2000). "Edg-1, the G protein-coupled receptor for sphingosine-
1-phosphate, is essential for vascular maturation." J Clin Invest 106(8): 951-61.

Lucarelli, E., A. Beccheroni, et al. (2003). "Platelet-derived growth factors enhance
proliferation of human stromal stem cells." Biomaterials 24(18): 3095-100.

Luyten, F. P. (2004). "Mesenchymal stem cells in osteoarthritis." Curr Opin Rheumatol
16(5): 599-603.

Lyncha, Kevin R., Timothy L. Macdonaldb. (2001) “Structure activity relationships of
lysophospholipid mediators” Prostaglandins & other Lipid Mediators 64: 33–45

McDonald, O. B., Hannun, Y. A., et al. (1991) “Activation of casein kinases II by
sphingosine.” J. Biol. Chem., 266: 21773-21776

Mackay, A. M., S. C. Beck, et al. (1998). "Chondrogenic differentiation of cultured
human mesenchymal stem cells from marrow." Tissue Eng 4(4): 415-28.

Mackenzie, T. C. and A. W. Flake (2001). "Human mesenchymal stem cells persist,
demonstrate site-specific multipotential differentiation, and are present in sites of wound
healing and tissue regeneration after transplantation into fetal sheep." Blood Cells Mol
Dis 27(3): 601-4.

MacLennan, AJ, Devlin BK, et al. (2000). “Antisense Studies in PC12 Cells Suggest a
Role for H218, a Sphingosine 1-Phosphate Receptor, in Growth-Factor-Induced Cell-Cell
Interaction and Neurite Outgrowth.” Dev Neurosci 22:283-295

Chapter 6 References

171
MacLennan, A. J., P. R. Carney, et al. (2001). "An essential role for the
H218/AGR16/Edg-5/LP(B2) sphingosine 1-phosphate receptor in neuronal excitability."
Eur J Neurosci 14(2): 203-9.

Madry, H., R. Padera, et al. (2002). "Gene transfer of a human insulin-like growth factor
I cDNA enhances tissue engineering of cartilage." Hum Gene Ther 13(13): 1621-30.

Malek, R. L., R. E. Toman, et al. (2001). "Nrg-1 belongs to the endothelial differentiation
gene family of G protein-coupled sphingosine-1-phosphate receptors." J Biol Chem
276(8): 5692-9.

Mandala, S., Richard Hajdu, et al. (2002) “Alteration of lymphocyte trafficking by
sphingosine-1-phosphate receptor agonists.” Science 296, 346-349.

Mansoor, M, and A.J. Melendez (2008) “Recent trials for FTY720 (fingolimod): a new
generation of immunomodulators structurally similar to sphingosine” Rev Recent Clin
Trials 3(1):62-9

Mastrogiacomo, M., R. Cancedda, et al. (2001). "Effect of different growth factors on the
chondrogenic potential of human bone marrow stromal cells." Osteoarthritis Cartilage 9
Suppl A: S36-40.

Mauck, R. L., B. A. Byers, et al. (2007). "Regulation of cartilaginous ECM gene
transcription by chondrocytes and MSCs in 3D culture in response to dynamic loading."
Biomech Model Mechanobiol 6(1-2): 113-25.

Mauney, J. R., V. Volloch, et al. (2005). "Matrix-mediated retention of adipogenic
differentiation potential by human adult bone marrow-derived mesenchymal stem cells

during ex vivo expansion." Biomaterials 26(31): 6167-75.

McGiffert C, Contos JJA, et al. (2002). “Embryonic brain expression analysis of
lysophospholipid receptor genes suggests roles for s1p1 in neurogenesis and s1p1-3 in
angiogenesis.” FEBS Lett., 531:103-108.

Megidish, T., White, T., et al. (1995) “The signal modulator protein 14-3-3 is a target of
sphingosine- or N,N-dimethylsphingosine-dependent kinase in 3T3(A31) cells.”
Biochem. Biophys. Res. Commun., 216: 739-747.

Melendez, A., R. A. Floto, et al. (1998). "FcgammaRI coupling to phospholipase D
initiates sphingosine kinase-mediated calcium mobilization and vesicular trafficking." J
Biol Chem 273(16): 9393-402.

Melendez, A. J., E. Carlos-Dias, et al. (2000). "Human sphingosine kinase: molecular
cloning, functional characterization and tissue distribution." Gene 251(1): 19-26.

Chapter 6 References

172
Melendez, A. J. and F. B. Ibrahim (2004). "Antisense knockdown of sphingosine kinase 1
in human macrophages inhibits C5a receptor-dependent signal transduction, Ca2+ signals,
enzyme release, cytokine production, and chemotaxis." J Immunol 173(3): 1596-603.

Melendez, A. J. and A. K. Khaw (2002). "Dichotomy of Ca2+ signals triggered by
different phospholipid pathways in antigen stimulation of human mast cells." J Biol
Chem 277(19): 17255-62.

Melendez, A.J. (2008). “Sphingosine kinase signalling in immune cells: potential as
novel therapeutic targets.” Biochim Biophys Acta 1784(1):66-75

Messina, E., L. De Angelis, et al. (2004). "Isolation and expansion of adult cardiac stem
cells from human and murine heart." Circ Res 95(9): 911-21.

Mets, T. and G. Verdonk (1981). "In vitro aging of human bone marrow derived stromal
cells." Mech Ageing Dev 16(1): 81-9.

Minamide, A., M. Yoshida, et al. (2007). "The effects of bone morphogenetic protein and
basic fibroblast growth factor on cultured mesenchymal stem cells for spine fusion."
Spine 32(10): 1067-71.

Miranville, A., C. Heeschen, et al. (2004). "Improvement of postnatal neovascularization
by human adipose tissue-derived stem cells." Circulation 110(3): 349-55.

Miyamoto, M., H. Ito, et al. (2003). "Simultaneous stimulation of EP2 and EP4 is
essential to the effect of prostaglandin E2 in chondrocyte differentiation." Osteoarthritis
Cartilage 11(9): 644-52.

Mizuno, H., P. A. Zuk, et al. (2002). "Myogenic differentiation by human processed
lipoaspirate cells." Plast Reconstr Surg 109(1): 199-209; discussion 210-1.

Monick, Martha M, Kelli Cameron, et al. (2004) “Sphingosine kinase mediates activation
of ERK and Akt by Respiratory Syncytial Virus.” Am. J. Respir. Cell Mol., 30: 844-52

Mori, A., Miyakawa, Y., Ohashi, E., Haga, T., et al. (2006) "Pd/C-Catalyzed
chemoselective hydrogenation in the presence of diphenylsulfide." Org. Lett., 8: 3279-
3281.

Morita, Y., G. I. Perez, et al. (2000). "Oocyte apoptosis is suppressed by disruption of the
acid sphingomyelinase gene or by sphingosine-1-phosphate therapy." Nat Med 6(10):

1109-14.

Mueller, S. M. and J. Glowacki (2001). "Age-related decline in the osteogenic potential
of human bone marrow cells cultured in three-dimensional collagen sponges." J Cell
Biochem 82(4): 583-90.

Chapter 6 References

173
Nair, R. P., T. Henseler, et al. (1997). "Evidence for two psoriasis susceptibility loci
(HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan."
Hum Mol Genet 6(8): 1349-56.

Nirmalanandhan, V. S., M. Rao, et al. (2007). "Effect of length of the engineered tendon
construct on its structure-function relationships in culture." J Biomech 40(11): 2523-9.

Nofer, J. R., M. van der Giet, et al. (2004). "HDL induces NO-dependent vasorelaxation
via the lysophospholipid receptor S1P3." J Clin Invest 113(4): 569-81.

Nunes, V. A., N. Cavacana, et al. (2007). "Stem cells from umbilical cord blood
differentiate into myotubes and express dystrophin in vitro only after exposure to in vivo
muscle environment." Biol Cell 99(4): 185-96.

Nussbaum, J, Minami E, et al. (2007) “Transplantation of undifferentiated murine
embryonic stem cells in the heart: teratoma formation and immune response.” FASEB J
21: 1345-1357

Ohnishi, S. and N. Nagaya (2007). "Prepare cells to repair the heart: mesenchymal stem
cells for the treatment of heart failure." Am J Nephrol 27(3): 301-7.

Ohta, H, Yatomi Y, et al. (1994) “A possible role of sphingosine in induction of
apoptosis by tumor necrosis factor-alpha in human neutrophils.” FEBS Lett, 355(3):267-
70

Okazaki H, Ishizaka N, et al. (1993) “Molecular cloning of a novel putative G protein-
coupled receptor expressed in the cardiovascular system.” Biochem Biophys Res
Commun.190 (3):1104–1109.

Olivera, A., T. Kohama, et al. (1999). "Sphingosine kinase expression increases
intracellular sphingosine-1-phosphate and promotes cell growth and survival." J Cell Biol
147(3): 545-58.

Olivera, A. and S. Spiegel (1993). "Sphingosine-1-phosphate as second messenger in cell
proliferation induced by PDGF and FCS mitogens." Nature 365(6446): 557-60.

Olivera, Ana, Nicole Urtz. (2006) “IgE-dependent Activation of Sphingosine Kinases 1
and 2 and Secretion of Sphingosine 1-Phosphate Requires Fyn Kinase and Contributes to
Mast Cell Responses.” J. Biol. Chem., 281(5): 2515-2525

Ong, S. Y., H. Dai, et al. (2006). "Hepatic differentiation potential of commercially
available human mesenchymal stem cells." Tissue Eng 12(12): 3477-85.

Orgretment, B., and Hannun, Y. A. (2004). “Biological active sphingolipids in cancer
pathogenesis and treatment.” Nat. Rev. Cancer 4, 604-616

Chapter 6 References

174
Orn, P. (1999). "Stem cells in the brain have been identified. Trials with human tissue
will confirm results from animal studies." Lakartidningen 96(10): 1212-4.

Oskeritzian, Carole A., Sheldon Milstien, et al., (2007) “Sphingosine-1-phosphate in
allergic responses, asthma and anaphylaxis.” Parmacol Ther. 115(3):390-99

Owen, M. and A. J. Friedenstein (1988). "Stromal stem cells: marrow-derived osteogenic
precursors." Ciba Found Symp 136: 42-60.

Ozaki, H., T. Hla, et al. (2003). "Sphingosine-1-phosphate signaling in endothelial
activation." J Atheroscler Thromb 10(3): 125-31.

Paik, J. H., A. Skoura, et al. (2004). "Sphingosine 1-phosphate receptor regulation of N-
cadherin mediates vascular stabilization." Genes Dev 18(19): 2392-403.

Payne, S. G., S. Milstien, et al. (2002). "Sphingosine-1-phosphate: dual messenger
functions." FEBS Lett 531(1): 54-7.

Paugh SW, Payne SG, et al. (2003) "The immunosuppressant FTY720 is phosphorylated
by sphingosine kinase type 2". FEBS Lett 554 (1–2): 189–93.

Pébay, A., R. C. Wong, et al. (2005). "Essential roles of sphingosine-1-phosphate and
platelet-derived growth factor in the maintenance of human embryonic stem cells." Stem
Cells 23(10): 1541-8.

Peng, H. and J. Huard (2003). "Stem cells in the treatment of muscle and connective
tissue diseases." Curr Opin Pharmacol 3(3): 329-33.

Perez, G. I., C. M. Knudson, et al. (1997). "Apoptosis-associated signaling pathways are
required for chemotherapy-mediated female germ cell destruction." Nat Med 3(11):
1228-32.

Pyne, S., J. Chapman, et al., (1996) “Sphingomyelin-derived lipids differentially regulate
the extracellular signal-regulated kinase 2 (ERK-2) and c-Jun N-terminal kinase (JNK)
signal cascades in airway smooth muscle.” Eur. J. Biochem. 237: 819–26.

Pettus, B. J., J. Bielawski, et al. (2003). "The sphingosine kinase 1/sphingosine-1-
phosphate pathway mediates COX-2 induction and PGE2 production in response to TNF-
alpha." Faseb J 17(11): 1411-21.

Phinney, D. G. and I. Isakova (2005). "Plasticity and therapeutic potential of
mesenchymal stem cells in the nervous system." Curr Pharm Des 11(10): 1255-65.

Pisati, F., M. Belicchi, et al. (2007). "Effect of human skin-derived stem cells on vessel
architecture, tumor growth, and tumor invasion in brain tumor animal models." Cancer
Res 67(7): 3054-63.
Chapter 6 References

175
Pisati, F., P. Bossolasco, et al. (2007). "Induction of neurotrophin expression via human
adult mesenchymal stem cells: implication for cell therapy in neurodegenerative
diseases." Cell Transplant 16(1): 41-55.

Pitson, S. M., J. D'Andrea R, et al. (2000). "Human sphingosine kinase: purification,
molecular cloning and characterization of the native and recombinant enzymes."
Biochem J 350 Pt 2: 429-41.

Pittenger, M. F., A. M. Mackay, et al. (1999). "Multilineage potential of adult human
mesenchymal stem cells." Science 284(5411): 143-7.

Planat-Benard, V., C. Menard, et al. (2004). "Spontaneous cardiomyocyte differentiation
from adipose tissue stroma cells." Circ Res 94(2): 223-9.

Prieschl, E. E. and T. Baumruker (2000). "Beyond a structural component: sphingolipids
in immunology." Arch Immunol Ther Exp (Warsz) 48(3): 163-71.

Prindull, G., B. Prindull, et al. (1978). "Haematopoietic stem cells (CFUc) in human cord
blood." Acta Paediatr Scand 67(4): 413-6.

Prockop, D. J. (1997). "Marrow stromal cells as stem cells for nonhematopoietic tissues."
Science 276(5309): 71-4.

Radu, E., O. Simionescu, et al. (2002). "Stem cells (p63(+)) in keratinocyte cultures from
human adult skin." J Cell Mol Med 6(4): 593-8.

Ramos, K. S., M. Hadi Falahatpisheh, et al. (2006). "Modulation of biological regulatory
networks during nephrogenesis." Drug Metab Rev 38(4): 677-83.

Rangappa, S., C. Fen, et al. (2003). "Transformation of adult mesenchymal stem cells
isolated from the fatty tissue into cardiomyocytes." Ann Thorac Surg 75(3): 775-9.
Reyes, M., T. Lund, et al. (2001). "Purification and ex vivo expansion of postnatal human
marrow mesodermal progenitor cells." Blood 98(9): 2615-25.

Rodriguez, A. M., C. Elabd, et al. (2005). "The human adipose tissue is a source of
multipotent stem cells." Biochimie 87(1): 125-8.

Roh, C., Q. Tao, et al. (2004). "Dermal papilla-induced hair differentiation of adult
epithelial stem cells from human skin." Physiol Genomics 19(2): 207-17.

Ronnstrand, L. and C. H. Heldin (2001). "Mechanisms of platelet-derived growth factor-
induced chemotaxis." Int J Cancer 91(6): 757-62.

Roviezzo, F., F. Del Galdo, et al. (2004). "Human eosinophil chemotaxis and selective in
vivo recruitment by sphingosine 1-phosphate." Proc Natl Acad Sci U S A 101(30):
11170-5.
Chapter 6 References

176
Ruck, P., J. C. Xiao, et al. (1996). "Hepatic stem cells in the human liver."
Histopathology 29(6): 590-2.

Safford, K. M. and H. E. Rice (2005). "Stem cell therapy for neurologic disorders:
therapeutic potential of adipose-derived stem cells." Curr Drug Targets 6(1): 57-62.

Safford, K. M., S. D. Safford, et al. (2004). "Characterization of neuronal/glial
differentiation of murine adipose-derived adult stromal cells." Exp Neurol 187(2): 319-28.

Sakakura, C, Sweeney EA, et al. (1996) “Suppression of bcl-2 gene expression by
sphingosine in the apoptosis of human leukemic HL-60 cells during phorbol ester-
induced terminal differentiation.” FEBS Lett. 379(2):177-80

Sammons, J., N. Ahmed, et al. (2004). "The role of BMP-6, IL-6, and BMP-4 in
mesenchymal stem cell-dependent bone development: effects on osteoblastic
differentiation induced by parathyroid hormone and vitamin D(3)." Stem Cells Dev 13(3):
273-80.

Santa Maria, L., C. V. Rojas, et al. (2004). "Signals from damaged but not undamaged
skeletal muscle induce myogenic differentiation of rat bone-marrow-derived
mesenchymal stem cells." Exp Cell Res 300(2): 418-26.

Sato, Y., H. Araki, et al. (2005). "Human mesenchymal stem cells xenografted directly to
rat liver are differentiated into human hepatocytes without fusion." Blood 106(2): 756-63.

Scavo, L. M., M. Karas, et al. (2004). "Insulin-like growth factor-I stimulates both cell
growth and lipogenesis during differentiation of human mesenchymal stem cells into
adipocytes." J Clin Endocrinol Metab 89(7): 3543-53.

Schaphorst, K. L., E. Chiang, et al. (2003). "Role of sphingosine-1 phosphate in the
enhancement of endothelial barrier integrity by platelet-released products." Am J Physiol
Lung Cell Mol Physiol 285(1): L258-67.

Schutze, N., U. Noth, et al. (2005). "Differential expression of CCN-family members in
primary human bone marrow-derived mesenchymal stem cells during osteogenic,
chondrogenic and adipogenic differentiation." Cell Commun Signal 3(1): 5.

Sekiya, I., B. L. Larson, et al. (2002). "Expansion of human adult stem cells from bone
marrow stroma: conditions that maximize the yields of early progenitors and evaluate
their quality." Stem Cells 20(6): 530-41.

Shea, C. M., C. M. Edgar, et al. (2003). "BMP treatment of C3H10T1/2 mesenchymal
stem cells induces both chondrogenesis and osteogenesis." J Cell Biochem 90(6): 1112-
27.

Chapter 6 References

177
Shin, S., Y. Sun, et al. (2007). "Whole genome analysis of human neural stem cells
derived from embryonic stem cells and stem and progenitor cells isolated from fetal
tissue." Stem Cells 25(5): 1298-306.

Shmelkov, S. V., S. Meeus, et al. (2005). "Cytokine preconditioning promotes
codifferentiation of human fetal liver CD133+ stem cells into angiomyogenic tissue."

Circulation 111(9): 1175-83.

Shu, S. N., L. Wei, et al. (2004). "Hepatic differentiation capability of rat bone marrow-
derived mesenchymal stem cells and hematopoietic stem cells." World J Gastroenterol
10(19): 2818-22.

Shu, X., W. Wu, et al. (2002). "Sphingosine kinase mediates vascular endothelial growth
factor-induced activation of ras and mitogen-activated protein kinases." Mol Cell Biol
22(22): 7758-68.

Simmons, P. J., B. Masinovsky, et al. (1992). "Vascular cell adhesion molecule-1
expressed by bone marrow stromal cells mediates the binding of hematopoietic
progenitor cells." Blood 80(2): 388-95.

Smythe, G. M. and M. D. Grounds (2000). "Exposure to tissue culture conditions can
adversely affect myoblast behavior in vivo in whole muscle grafts: implications for
myoblast transfer therapy." Cell Transplant 9(3): 379-93.

Solchaga, L. A., K. Penick, et al. (2005). "FGF-2 enhances the mitotic and chondrogenic
potentials of human adult bone marrow-derived mesenchymal stem cells." J Cell Physiol
203(2): 398-409.

Song, H. Y., E. S. Jeon, et al. (2007). "Oncostatin M promotes osteogenesis and
suppresses adipogenic differentiation of human adipose tissue-derived mesenchymal stem
cells." J Cell Biochem 101(5): 1238-51.

Sotiropoulou, P. A., S. A. Perez, et al. (2006). "Cell culture medium composition and
translational adult bone marrow-derived stem cell research." Stem Cells 24(5): 1409-10.
Spiegel, S., O. Cuvillier, et al. (1998). "Sphingosine-1-phosphate in cell growth and cell
death." Ann N Y Acad Sci 845: 11-8.

Spiegel, S. and S. Milstien (1996). "Sphingoid bases and phospholipase D activation."
Chem Phys Lipids 80(1-2): 27-36.

Spiegel, S. and S. Milstien (2000). "Functions of a new family of sphingosine-1-
phosphate receptors." Biochim Biophys Acta 1484(2-3): 107-16.

Spiegel, S. and S. Milstien (2002). "Sphingosine 1-phosphate, a key cell signaling
molecule." J Biol Chem 277(29): 25851-4.

Chapter 6 References

178
Spiegel, S. and S. Milstien (2003). "Sphingosine-1-phosphate: an enigmatic signalling
lipid." Nat Rev Mol Cell Biol 4(5): 397-407.

Siess, W., M. Essler, et al. (2000) “Lysophosphatidic acid and sphingosine 1-phosphate:
two lipid villains provoking cardiovascular diseases?” IUBMB Life 49:167–171.

Stenderup, K., J. Justesen, et al. (2003). "Aging is associated with decreased maximal life
span and accelerated senescence of bone marrow stromal cells." Bone 33(6): 919-26.

Suzuki, Erika, Kazuko Handa, et al. (2004) “Sphingosine-dependent apoptosis: A unified
concept based on multiple mechanisms operating in concert.” Proc Natl Acad Sci 101(41):
14788–14793

Sweeneyc, Elizabeth A., Uhei Sakakurat, et al. (1996) “Sphingosine and its methylated
derivative in a variety of human cancer cell lines.” Int. J. Cancer: 66,358-366

Taha, T. A., Y. A. Hannun, et al. (2006). "Sphingosine kinase: biochemical and cellular

regulation and role in disease." J Biochem Mol Biol 39(2): 113-31.

Takagi, M., Y. Umetsu, et al. (2007). "High inoculation cell density could accelerate the
differentiation of human bone marrow mesenchymal stem cells to chondrocyte cells." J
Biosci Bioeng 103(1): 98-100.

Tao, H., R. Rao, et al. (2005). "Cytokine-induced stable neuronal differentiation of
human bone marrow mesenchymal stem cells in a serum/feeder cell-free condition." Dev
Growth Differ 47(6): 423-33.

Thomson, J. A., J. Itskovitz-Eldor, et al. (1998). "Embryonic stem cell lines derived from
human blastocysts." Science 282(5391): 1145-7.

Trivedi, P. and P. Hematti (2007). "Simultaneous generation of CD34+ primitive
hematopoietic cells and CD73+ mesenchymal stem cells from human embryonic stem
cells cocultured with murine OP9 stromal cells." Exp Hematol 35(1): 146-54.

Tropel, P., N. Platet, et al. (2006). "Functional neuronal differentiation of bone marrow-
derived mesenchymal stem cells." Stem Cells 24(12): 2868-76.

Tseng, S. C. and D. Q. Li (1996). "Comparison of protein kinase C subtype expression
between normal and aniridic human ocular surfaces: implications for limbal stem cell
dysfunction in aniridia." Cornea 15(2): 168-78.

Tsonis, P. A. (1991). "1,25-Dihydroxyvitamin D3 stimulates chondrogenesis of the chick
limb bud mesenchymal cells." Dev Biol 143(1): 130-4.

Chapter 6 References

179

Tsuchiya, H., H. Kitoh, et al. (2003). "Chondrogenesis enhanced by overexpression of
sox9 gene in mouse bone marrow-derived mesenchymal stem cells." Biochem Biophys
Res Commun 301(2): 338-43.

Tsutsumi, S., A. Shimazu, et al. (2001). "Retention of multilineage differentiation
potential of mesenchymal cells during proliferation in response to FGF." Biochem
Biophys Res Commun 288(2): 413-9.

Uccelli, A., E. Zappia, et al. (2006). "Stem cells in inflammatory demyelinating disorders:
a dual role for immunosuppression and neuroprotection." Expert Opin Biol Ther 6(1): 17-
22.

Van Brocklyn, J. R., M. H. Graler, et al. (2000). "Sphingosine-1-phosphate is a ligand for
the G protein-coupled receptor EDG-6." Blood 95(8): 2624-9.

Van den Bos, C., J. D. Mosca, et al. (1997). "Human mesenchymal stem cells respond to
fibroblast growth factors." Hum Cell 10(1): 45-50.

Van Veldhoven, P. P., R. J. Foglesong, et al. (1989). "A facile enzymatic synthesis of
sphingosine-1-phosphate and dihydrosphingosine-1-phosphate." J Lipid Res 30(4): 611-6.
Vilquin, J. T. and P. Rosset (2006). "Mesenchymal stem cells in bone and cartilage repair:
current status." Regen Med 1(4): 589-604.

Visentin, B., J. A. Vekich, et al. (2006). "Validation of an anti-sphingosine-1-phosphate
antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in
multiple tumor lineages." Cancer Cell 9(3): 225-38.

Vogel, G. (2005) “Cell Biology. Ready or not? Human ES cells head toward the clinic.”
Science, 308: 1534-1538

Wakitani, S, Takaoka K, et al. (2003) “Embryonic stem cells injected into the mouse
knee joint form teratomas and subsequently destroy the join.” Rheumatology (Oxford)
42:162-165
Wall, M. E., S. H. Bernacki, et al. (2007). "Effects of serial passaging on the adipogenic
and osteogenic differentiation potential of adipose-derived human mesenchymal stem
cells." Tissue Eng 13(6): 1291-8.

Wang, F., N. E. Buckley, et al. (1996). "Involvement of sphingolipids metabolites in
cellular proliferation modulated by ganglioside GM1." Glycoconj J 13(6): 937-45.

Wang, F., J. R. Van Brocklyn, et al. (1999). "Sphingosine 1-phosphate stimulates cell
migration through a G(i)-coupled cell surface receptor. Potential involvement in
angiogenesis." J Biol Chem 274(50): 35343-50.

Chapter 6 References

180
Wang, Wengang, Markus H. Graeler, et al. (2005) “Type 4 sphingosine 1-phosphate G
protein-coupled receptor (S1P
4
) transduces S1P effects on T cell proliferation and
cytokine secretion without signaling migration” The FASEB. 19:1731-1733

Wang, Z., J. Goh, et al. (2006). "Efficacy of bone marrow-derived stem cells in
strengthening osteoporotic bone in a rabbit model." Tissue Eng 12(7): 1753-61.

Watternberg, Brinks W., Stuart M. Pitson, et al. (2006) “The sphingosine and
diacylglycerol kinase superfamily of signaling kinases: localization as a key to signaling
function” J Lipid Research, 47:1128-1139

Wiehe, J. M., O. Zimmermann, et al. (2005). "Labeling of adult stem cells for in vivo-
application in the human heart." Histol Histopathol 20(3): 901-6.

Wilmut, I., M. D. West, et al. (2005). "Human embryonic stem cells." Science 310(5756):
1903.
Wu, W., R. D. Mosteller, et al. (2004). "Sphingosine kinase protects lipopolysaccharide-
activated macrophages from apoptosis." Mol Cell Biol 24(17): 7359-69.

Wu, J., S. Spiegel et al., (1995) “Sphingosine 1-phosphate rapidly activates the mitogen-
activated protein kinase pathway by a G protein-dependent mechanism” J. Biol. Chem.
270:11484–8

Xia, P., J. R. Gamble, et al. (1998). "Tumor necrosis factor-alpha induces adhesion
molecule expression through the sphingosine kinase pathway." Proc Natl Acad Sci U S A
95(24): 14196-201.

Xia, P., J. R. Gamble, et al. (2000). "An oncogenic role of sphingosine kinase." Curr Biol
10(23): 1527-30.

Xia, P., L. Wang, et al. (1999). "Activation of sphingosine kinase by tumor necrosis
factor-alpha inhibits apoptosis in human endothelial cells." J Biol Chem 274(48): 34499-
505.

Xu, C. B., J. Hansen-Schwartz, et al. (2004). "Sphingosine signaling and atherogenesis."
Acta Pharmacol Sin 25(7): 849-54.

Xu, C. B., Y. Zhang, et al. (2002). "D-erythro-N,N-dimethylsphingosine inhibits bFGF-
induced proliferation of cerebral, aortic and coronary smooth muscle cells."
Atherosclerosis 164(2): 237-43.

Yagi, H., R. Kamba, et al. (2000). "Immunosuppressant FTY720 inhibits thymocyte
emigration." Eur J Immunol 30(5): 1435-44.

Chapter 6 References

181
Yamaguchi, F., Tokuda, M., et al. (1996) “Molecular cloning of the novel human G
protein-coupled receptor (GPCR) gene mapped on chromosome 9.” Biochem. Biophys.
Res. Commun. 227, 608-614.

Yamazaki, Y., J. Kon, et al. (2000). "Edg-6 as a putative sphingosine 1-phosphate
receptor coupling to Ca(2+) signaling pathway." Biochem Biophys Res Commun 268(2):
583-9.

Yang, J., Q. Y. Xie, et al. (2007). "[Differentiation of QY1 bone marrow pluripotential
mesenchymal stem cell line cells into cardiomyocytes and vascular endothelial cells in
vitro]." Zhong Nan Da Xue Xue Bao Yi Xue Ban 32(1): 93-8.

Yang, Libo, Yutaka Yatomi, et al. (1999) “Sphingosine 1-Phosphate Formation and
Intracellular Ca2+ Mobilization in Human Platelets: Evaluation with Sphingosine Kinase
Inhibitors1.” J. Biochem. 126, 84-89

Yatomi, Y., Y. Igarashi, et al. (1997). "Sphingosine 1-phosphate, a bioactive sphingolipid
abundantly stored in platelets, is a normal constituent of human plasma and serum." J
Biochem (Tokyo) 121(5): 969-73.

Yen, Men-luh, Chih-Cheng Chien, et al. (2007) “Multilineage differentiation and
characterization of the human fetal osteoblastic 1.19 cell line: a possible in vitro model of
human mesenchymal progenitors.” Stem Cells 25: 125 -131

Yim, E. K., S. W. Pang, et al. (2007). "Synthetic nanostructures inducing differentiation
of human mesenchymal stem cells into neuronal lineage." Exp Cell Res 313(9): 1820-9.

Young, H. E., T. A. Steele, et al. (2001). "Human reserve pluripotent mesenchymal stem
cells are present in the connective tissues of skeletal muscle and dermis derived from
fetal, adult, and geriatric donors." Anat Rec 264(1): 51-62.

Zahradka, Peter, Jeffrey P. Werner, et al. (2002). “NF-κB Activation is Essential for
angiotensin II-dependent Proliferation and Migration of Vascular Smooth Muscle Cells”.
J. Mol. Ce. Card. 34(12):1609-21.

Zaragosi, L. E., G. Ailhaud, et al. (2006). "Autocrine fibroblast growth factor 2 signaling
is critical for self-renewal of human multipotent adipose-derived stem cells." Stem Cells
24(11): 2412-9.

Zhang, H., N. N. Desai, et al. (1991). "Sphingosine-1-phosphate, a novel lipid, involved
in cellular proliferation." J Cell Biol 114(1): 155-67.

Zhang, G., Contos, J. J., et al. (1999) “Comparative analysis of three murine G-protein
coupled receptors activated by sphingosine-1-phosphate.” Gene (Amst.) 227:89-99

Chapter 6 References

182
Zhang, S., J. Ge, et al. (2006). "Comparison of various kinds of bone marrow stem cells
for the repair of infarcted myocardium: single clonally purified non-hematopoietic
mesenchymal stem cells serve as a superior source." J Cell Biochem 99(4): 1132-47.

Zhi, L., B. P. Leung, et al. (2006). "Sphingosine kinase 1 regulates pro-inflammatory
responses triggered by TNFalpha in primary human monocytes." J Cell Physiol 208(1):

109-15.

Zieske, J. D., G. Bukusoglu, et al. (1992). "Characterization of a potential marker of
corneal epithelial stem cells." Invest Ophthalmol Vis Sci 33(1): 143-52.

Zohar, R., J. Sodek, et al. (1997). "Characterization of stromal progenitor cells enriched
by flow cytometry." Blood 90(9): 3471-81.

Zuk, P. A., M. Zhu, et al. (2002). "Human adipose tissue is a source of multipotent stem
cells." Mol Biol Cell 13(12): 4279-95.

Zuk, P. A., M. Zhu, et al. (2001). "Multilineage cells from human adipose tissue:
implications for cell-based therapies." Tissue Eng 7(2): 211-28.

Efficacy and safety of fingolimod in patients with relapsing-remitting multiple sclerosis.
Clinical Trials.gov (2007-08-20). Retrieved on 2007-11-06